These tools set cookies that store anonymised information about how you got to the site, and how you interact with the site.

In the talks both ourselves and NHS England continued to offer as much flexibility as possible, but despite the intervention of Secretary of State for Health Wes Streeting, the companies did not put ...

Two technologies that could reduce the severity of the symptoms of chronic tic disorders and Tourette syndrome have been recommended for use in draft guidance from NICE. It is the first time a NICE ...

Are you facing challenges in quickly bringing new healthtech products to market? The NHS is a large and complex system and ...

According to the study, technologies that received scientific advice took a median of 312 days to progress from marketing authorisation to NICE guidance publication. In contrast, those without such ...

There is a simple discount patient access scheme for elafibranor. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NHS organisations can contact ...

This summary report is based on the NICE assumptions used in the resource impact template. Users can amend the 'Inputs and eligible population' and 'Unit costs' worksheets in the template to reflect ...

You should read both the consultation document and the accompanying evidence (see the committee papers) before making any comments. You must make your comments ...

The 4 technology appraisal committees are standing advisory committees of NICE. This topic was considered by committee C. Committee members are asked to declare any interests in the technology being ...

This procedure should only be done as part of a formal research study, and a research ethics committee needs to have approved its use.

Discontinued. Please note that following on from information provided to NICE by the company in January 2022, the appraisal was suspended from NICE’s work programme. As no further information has been ...